MedTrace Logo

New Biomarkers of Neurological Outcome After a Sudden Cardiac Death

NCT03962361 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2019-05-24

No results posted yet for this study

Summary

The aim of the project is to establish the value of circulating microparticles as a new biomarker for neurological prognosis of patients recovered from sudden cardiac death who remain comatose.

Conditions

  • Cardiac Sudden Death
  • Hypoxia Brain
  • Cell Membrane Microparticles
  • Biomarkers

Interventions

OTHER

Concentration of circulating microparticles.

The microparticles contained in the blood sample will be isolated by ultracentrifugation and quantified by flow cytometry. The microparticles concentration will be determined by the number of microparticles per uL of plasma, based on the volume of the sample, the flow rate of the cytometer and the number of fluorescent events.

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Laia C Belarte, Doctor · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2019-09-30
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03962361 on ClinicalTrials.gov